Stock News Recap: Stereotaxis, Inc. (NYSE: STXS)

Health and Biotech

On 04 Nov 2019, Stereotaxis, Inc. (NYSE: STXS) witnessed a gain of 1.67% in recent trading period with closing price of $3.65. The company’s last traded volume of 117522 shares vs to an average volume of 135.41K shares. In the profitability analysis, net profit margin of the firm was recorded at -19.80% and operating profit margin was calculated at -14.80% while gross profit margin was measured as 80.40%. Beta factor, which measures the riskiness of the security, was registered at 1.53.

Stereotaxis (NYSE American: STXS) and ADAS 3D Medical SL recently reported the first patients have been successfully treated with the integration of ADAS 3D’s advanced preoperative substrate mapping and Stereotaxis’ Robotic Magnetic Navigation technologies.

“Life-threatening arrhythmias are ordinary in patients that have suffered a myocardial infarction. Cardiac ablation can help these patients, but often require extensive searching to find targets and widespread ablation to ensure all problematic tissue has been addressed,” stated Prof. Pedro Adragao. “ADAS 3D supports rapid and precise identification of such tissue. We have long recognized the clinical value of Robotic Magnetic Navigation to treat patients with precision and safety. The integration of both technologies should result in more effective, rapid, and safe procedures for patients.”

“Combining our technology with Stereotaxis is an exciting prospect that we believe will positively impact the field of Electrophysiology,” stated Luis Serra, President of ADAS 3D Medical. “The ability to translate combined MRI and CT images into 3D coordinates of the patient’s heart and then use robotics for precision navigation of therapy should provide more reproducible treatment during cardiac ablation. We hope this will benefit health care professionals and their patients.”

The Company has 65.15 million shares outstanding and 50.6 million shares were floated in market. The short ratio in the company’s stock is documented at 1.59 and the short float is around of 0.43%. The average true range of the stock is observed at 0.21 and the relative strength index of the stock is recorded at 55.93.